← Leaderboards
Daniel F. Hayes
Georgetown University
$1,994,971
Attributed
$1,994,971
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $614.9K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$1,994,971 · 8
By mechanism
R01$1,389,335 · 1
M01$456,901 · 5
U10$148,735 · 1
N01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- David Alastair Flockhart$24,746,163
- Joyce Marie Slingerland$12,812,016
- Edward P Gelmann$8,316,737
- Kevin J Cullen$20,041,785
- Susan F Honig$405,870
Others in their field
Top investigators on “Neoplasm /Cancer Chemotherapy”
- Charles A Coltman · Southwest Oncology Group$171,655,324
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Philip J Disaia · University Of California Irvine$41,530,194
- Walter J Curran · Thomas Jefferson University$37,520,030
- Samuel A Wells · Duke University$32,148,803
- Gregory H Reaman · National Childhood Cancer Foundation$19,436,422
Research focus
Neoplasm /Cancer ChemotherapyClinical ResearchPaclitaxelBreast NeoplasmsHuman SubjectDrug Adverse EffectTamoxifenP53 Gene /ProteinHuman Therapy EvaluationFemaleDrug ResistanceDoxorubicinGene MutationCombination ChemotherapyApoptosisGrantAntisense Nucleic AcidHot FlushesFundingDrug Screening /EvaluationGene ExpressionFluorescent In Situ HybridizationComputer Retrieval Of Information On Scientific Projects DatabaseBcl2 Gene /Protein
Grant awards (13)
EFFECTS OF EXEMESTANE OR LETROZOLE ON SURROGATE MARKERS OF RESPONSE$34,347
M01 · FY2007 · RR · contact PI
PILOT TRIAL CORRELATING METABOLIC PROFILE OF TAMOXIFEN WITH HOT FLASHES$12,879
M01 · FY2007 · RR · contact PI
PILOT TRIAL CORRELATING METABOLIC PROFILE OF TAMOXIFEN WITH HOT FLASHES$101,172
M01 · FY2006 · RR · contact PI
A MULTI-CENTER RANDOMIZED CLINICAL TRIAL CORRELATING THE EFFECTS OF 24 MONTHS OF$1,022
M01 · FY2006 · RR · contact PI
Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.$453,275
R01 · FY2005 · CA
PILOT TRIAL CORRELATING METABOLIC PROFILE OF TAMOXIFEN WITH HOT FLASHES$161,599
M01 · FY2005 · RR
Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.$453,203
R01 · FY2004 · CA
Pilot Trial Correlating Metabolic Profile of Tamoxifen with Hot Flashes$145,882
M01 · FY2004 · RR
Correlative Studies of erbB-2/HER2 and p53 in CALGB Pro.$482,857
R01 · FY2003 · CA
CANCER AND ACUTE LEUKEMIA GROUP B (CALGB) INST GRANT$148,735
U10 · FY2000 · CA
Docetaxel (Taxotere) &BCL-2-Antisense Oligonucleotide$0
M01 · FY2000 · RR
PHASE 2 CLINICAL TRIALS OF OLTIPRAZ IN BREAST NEOPLASIA$0
N01 · FY2000 · CN
Docetaxel (Taxotere) &BCL-2-Antisense Oligonucleotide$0
M01 · FY2000 · RR